Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus neostigmine added to bupivacaine for post-cesarean pain after spinal anesthesia
IRCT20161126031095N2Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in postprocedural pain (CPSP) comparing Dexmedetomidine + bupivacaine with Neostigmine + bupivacaine (2 arms). Primary endpoints: Pain intensity, Sedation and 1 more. Started Dec 2020; status: completed.
02
Drugs
dexmedetomidineneostigminebupivacaine
03
Conditions
postprocedural pain (CPSP)
Beyond the preview
Go deeper on IRCT20161126031095N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161126031095N2.